Cancer Stem Cells: Know Thine Enemy

	Tweet

Stem cells—popularly known as a source of biological rejuvenation—may play harmful roles in the body, specifically in the growth and spread of cancer. Amongst the wildly dividing cells of a tumor, scientists have located cancer stem cells. Physician-scientists from Weill Cornell Medical College are studying these cells with hopes of combating malignant cancers in the brain.

“Some patients’ brain tumors respond to chemotherapy and some don’t,” says Dr. John A. Boockvar, the Alvina and Willis Murphy Assistant Professor of Neurological Surgery and head of the Brain Tumor Research Group at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. “We believe cancer stem cells may be the cause.”

Dr. Boockvar is capturing and classifying these cancer stem cells in order to determine how they react to certain available drug therapies. Doing so will lead to more accurate and specific cancer diagnosis, allowing for tailored drug treatments. Results explaining the techniques used to harvest normal neural and brain-tumor-derived stem cells will be described in the January 2008 edition of the journal Neurosurgery.

“Cataloging brain tumor stem cells will be an enormous tool for patient diagnosis,” explains Dr. Boockvar, “but it will also help to create a library of knowledge for the scientific community to understand how brain tumors form and to test and develop new drugs.”

To stave off cancer stem cell growth in the brain, Dr. Boockvar is studying the use of two drugs already available for cancer treatment. Tarceva—approved for the treatment of lung and pancreatic cancer—works by stopping the growth and spread of cancer cells. Avastin—approved for the treatment of colorectal cancers—is also being studied for inhibiting cancer cell growth and works by stopping the growth of blood vessels (angiogenesis) that feed the tumor.

Preliminary results from these trials have shown that some patients’ cancers are wiped out, whereas others remain resistant. Dr. Boockvar believes that these patients’ drug resistance might be due to a class of stem cells resilient to available treatments. Finding biomarkers that distinguish these stem cells from those that are destroyed by known drugs might help researchers formulate new drugs.

“Determining a patient’s cancer stem cell profile will take a lot of the guessing out of choosing a course of treatment,” says Dr. Boockvar. “It will save money, medical resources and precious time for the patient.”

NewYork-Presbyterian Hospital/Weill Cornell Medical Center

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, located in New York City, is one of the leading academic medical centers in the world, comprising the teaching hospital NewYork-Presbyterian and Weill Cornell Medical College, the medical school of Cornell University. NewYork-Presbyterian/Weill Cornell provides state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine, and is committed to excellence in patient care, education, research and community service. Weill Cornell physician-scientists have been responsible for many medical advances—from the development of the Pap test for cervical cancer to the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial for gene therapy for Parkinson’s disease, the first indication of bone marrow’s critical role in tumor growth, and, most recently, the world’s first successful use of deep brain stimulation to treat a minimally-conscious brain-injured patient. NewYork-Presbyterian, which is ranked sixth on the U.S.News & World Report list of top hospitals, also comprises NewYork-Presbyterian Hospital/Columbia University Medical Center, Morgan Stanley Children’s Hospital of NewYork-Presbyterian, NewYork-Presbyterian Hospital/Westchester Division and NewYork-Presbyterian Hospital/The Allen Pavilion. Weill Cornell Medical College is the first U.S. medical college to offer a medical degree oversees and maintains a strong global presence in Austria, Brazil, Haiti, Tanzania, Turkey and Qatar.

Source: NewYork-Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College

RELATED STORIES:
Few people are doing it, so why should I? Motivating men to seek cancer screening   New Research Suggests Ways to Improve Cancer Therapy   Alcohol and cancer: is drinking the new smoking?   Researcher Investigates Ultrasound Use to Treat Cancer   New Study Begins for Kids With High-Risk Cancer   Study Predicts Dramatic Growth in Cancer Rates Among U.S. Elderly, Minorities   New study widens cancer risks and benefits of pill   Mobile Phone Use Not Linked to Increased Risk of Glioma Brain Tumours   American Cancer Society report details cancer prevention efforts   Mistletoe extract may treat bladder cancer   Mayo Clinic study shows Parkinson’s disease drug might work in cancer patients   Cancer drug may fight smallpox, study suggests   Researchers Examine Use of Toad Venom in Cancer Treatment   Study Finds Improvement in the Care of Children with Cancer at the End of Life   U-S Cancer Death Rates in Decline, National Report Finds   Potential New Therapeutic Molecular Target to Fight Cancer   Cancer Cases and Deaths are preventable   Habits explain poor women’s worse cancer outcome   Snoring ‘can raise cancer risk five-fold’   Workers in No-Smoking Restaurants Show Lower Carcinogen Levels   Why Some Tumors Don’t Respond to Radiation and Chemotherapy   Monoclonal Antibody Drugs for Cancer Treatment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]